If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Masatoshi Eto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Renal Cell Carcinoma Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Urinary Bladder Neoplasms Medicine & Life Sciences
Androgens Medicine & Life Sciences
Kidney Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1987 2019

1 Citation (Scopus)

Assessment of surgical skills by using surgical navigation in robot-assisted partial nephrectomy

Kobayashi, S., Cho, B., Huaulmé, A., Tatsugami, K., Honda, H., Jannin, P., Hashizumea, M. & Eto, M., Aug 1 2019, In : International Journal of Computer Assisted Radiology and Surgery. 14, 8, p. 1449-1459 11 p.

Research output: Contribution to journalArticle

Nephrectomy
Navigation
Robots
Robotics
Surgical Instruments
1 Citation (Scopus)

Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone

shiota, M., Narita, S., Akamatsu, S., Fujimoto, N., Sumiyoshi, T., Fujiwara, M., Uchiumi, T., Habuchi, T., Ogawa, O. & Eto, M., Feb 1 2019, In : JAMA network open. 2, 2, p. e190115

Research output: Contribution to journalArticle

Open Access
Androgens
Prostatic Neoplasms
Odds Ratio
Therapeutics
Castration
Androgen Antagonists
Androgen Receptors
docetaxel
Prostatic Neoplasms
Smoking

Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma

the Japanese Society of Renal Cancer, Jun 1 2019, In : Cancer Science. 110, 6, p. 1820-1828 9 p.

Research output: Contribution to journalArticle

Open Access
Tumor Microenvironment
Renal Cell Carcinoma
Ligands
Neoplasms
Protein-Tyrosine Kinases

Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study

shiota, M., Nakamura, M., Yokomizo, A., Tomoda, T., Sakamoto, N., Seki, N., Hasegawa, S., Yunoki, T., Harano, M., Kuroiwa, K. & Eto, M., Sep 1 2019, In : Cancer chemotherapy and pharmacology. 84, 3, p. 561-566 6 p.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Hazards
Safety
Confidence Intervals